⌘K

Login Start Free

Home/Filings/4/0001209191-16-115339

4//SEC Filing

ZIOPHARM ONCOLOGY INC 4

Accession 0001209191-16-115339

$TCRTCIK 0001107421operating

View on SEC.gov Company Profile

Filed

Apr 21, 8:00 PM ET

Accepted

Apr 22, 4:47 PM ET

Size

6.9 KB

Accession

0001209191-16-115339

Insider Transaction Report

Form 4

Period: 2016-04-21

ZIOPHARM ONCOLOGY INCZIOP

CANNON JAMES ANTHONY

Director

Transactions

Exercise/Conversion
Common Stock
2016-04-21$5.01/sh+15,000$75,150→ 341,963 total
Exercise/Conversion
Stock Option (right to buy)
2016-04-21−15,000→ 0 total
Exercise: $5.01From: 2006-04-26Exp: 2016-04-26→ Common Stock (15,000 underlying)

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001107421

Filing Metadata

Form type: 4
Filed: Apr 21, 8:00 PM ET
Accepted: Apr 22, 4:47 PM ET
Size: 6.9 KB

View on SEC.gov